GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...